The Obesity Drug Loophole. Plus, the Outlook for Homebuilder Stocks.
Barron's Streetwise
Outlook for Homebuilder Stocks and Performance of Artificial Intelligence Stocks
The chapter analyzes the positive transformation of homebuilder stocks post-global financial crisis and mentions the performance of artificial intelligence stocks including HIMS and HERS Health, a telemedicine company selling generic drugs.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
